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 2 
Abstract  1 
 2 
The standard representation of the Central Dogma (CD) of Molecular Biology conspicuously ignores 3 
metabolism. However, both the metabolites and the biochemical fluxes behind any biological 4 
phenomenon are encrypted in the DNA sequence. Metabolism constrains and even changes the 5 
information flow when the DNA-encoded instructions conflict with the homeostasis of the biochemical 6 
network. Inspection of adaptive virulence programs and emergence of xenobiotic-biodegradation 7 
pathways in environmental bacteria suggest that their main evolutionary drive is the expansion of their 8 
metabolic networks towards new chemical landscapes rather than perpetuation and spreading of their 9 
DNA sequences. Faulty enzymatic reactions on suboptimal substrates produce reactive oxygen species 10 
(ROS), which fosters DNA diversification and eventually couples catabolism of the new chemicals to 11 
growth. All this calls for a revision of the CD in which metabolism (rather than DNA) has the leading role. 12 
 13 
Introduction 14 
 15 
How do biological systems adapt to changing environments and evolve to thrive in new physicochemical 16 
/ nutritional niches? The textbook answer to this question is a combination of classical Darwinian theory 17 
and modern Molecular Biology [1]: DNA mutates randomly to bring about a phenotypic diversification of 18 
the biological object (from proteins to entire organisms) that explores the solution space until one variant 19 
gains a competitive advantage that enables it to reproduce better, thereby reaching a new fitness peak 20 
[2]. The implicit framework of the process is epitomized in the so-called central dogma (CD) of 21 
Molecular Biology (CD, Fig. 1a). The tenet DNA makes RNA makes protein [3,4] accounts for the flow of 22 
information in every biological system. Note that the term information applied to biological systems is 23 
often loosely defined, as it may refer either to that encoded in a sequence or that borne by a given 24 
context e.g. compositional or architectural information (see [5-8] for pro and con views). In any case, 25 
diversification of DNA at the top of the schema is considered the key occurrence for implementing an 26 
evolutionary solution-seeking drive, a job mostly done by the downstream proteins. Whether one 27 
considers the more general or the special version (i.e., taking into account RNA self-replication and 28 
retro-transcription back to DNA), the CD is based on two essential pillars: [i] that DNA, and RNA are the 29 
sole holders and transmitters of residue-by-residue information to proteins and [ii] that such information 30 
is basically unidirectional, with the occasional exception of back-copying RNA à DNA which, of itself, 31 
 3 
makes no provision for information transfer from proteins back to nucleic acids. This state of affairs 1 
places DNA atop the hierarchy of actors that rule the functioning of living systems and orchestrate their 2 
adaptation to novel niches. Further inspection of the CD on the background of recent results on the way 3 
in which pathogens interact with their hosts and environmental bacteria biodegrade xenobiotic 4 
chemicals reveal, however, some inconsistencies in the scheme of Fig. 1a that are worth considering as 5 
detailed below.  6 
 7 
The canonical CD ignores metabolism 8 
 9 
The information stream of the canonical CD ends, astonishingly, in proteins. But … is that the actual 10 
finale of the flow? Is there nothing downstream of proteins? Where is metabolism? It is surprising that 11 
such a conspicuous absence has essentially been overlooked for so long. Many proteins are enzymes 12 
that transform chemicals into nutrients and metabolize such nutrients into all types of building blocks for 13 
living systems. The cognate catalytic properties of proteins are certainly encrypted in their primary 14 
amino acid sequence, itself encoded in DNA. However, the residue-by-residue transfer of information 15 
does not apply in this case, as one cannot predict chemical structures of metabolites or their fluxes 16 
directly from the genes involved. But metabolites, biochemical reactions and ensuing fluxes are, indeed, 17 
encoded – albeit in a more intricate way, in the DNA sequence. Computational de-convolution of such 18 
non-trivial information has allowed, for instance, the development of metabolic models from the sole 19 
source of genomic sequences [9-12]. On this basis, a necessary qualification of the CD involves, at the 20 
least, the explicit addition of one more layer of information transfer: protein à metabolism (Fig. 1b).  21 
 22 
A separate issue regards the connectivity of the CD flowchart with the environment. The naked scheme 23 
of Fig. 1a would suggest that DNA, RNA and proteins are self-perpetuating objects with no links to their 24 
surroundings. Once more metabolism comes into play: it not only provides the building blocks for the 25 
other components of the CD, but also becomes the boundary between the biological and non-biological 26 
realms. This should also become clear in a streamlined representation of the dogma: the operation of 27 
the information flow depends on the availability of suitable metabolic precursors, cofactors and signals 28 
for synthesizing the canonical information-bearing polymers. The step from DNA to RNA (transcription) 29 
is checked by the archetypal metabolic “alarmone” ppGpp (an intracellular signalling molecule that is 30 
produced in response to harsh environmental conditions [13] and strongly influenced by somewhat 31 
 4 
inconspicuous molecules such as α-ketoglutarate [14]. Starvation-associated stress is known to cause 1 
errors in DNA [15,16] and to alter translation – besides leading to oxidative stress due to deficiency in 2 
NADPH production by glucose-6-P dehydrogenase and other enzymes of the pentoses cycle [17]. Even 3 
the rather inexplicable distribution of CG content in bacterial genomes can be traced to the metabolic 4 
bottleneck that creates the transition G/C à A/T [18]. And so the examples continue. 5 
 6 
A third problem of the official CD is the explicit hierarchy of the actors: DNA gives instructions to RNA, 7 
which gives instructions to proteins which (at least in the expanded plot of Fig. 1b) rule metabolism. This 8 
scheme (the DNA on top, the other performers below) embodies the view that DNA is the master 9 
component of any biological system, and that the others constitute a cohort of servants that execute the 10 
orders emanating from the top. One of the extreme interpretations that springs from the CD as a chain 11 
of command is the metaphor of the selfish gene. The concept, brilliantly elaborated by Richard Dawkins 12 
in his famous 1976 book, was opportunely published first at the onset of the recombinant DNA era [19]. 13 
The main claim of the title is that the sole agenda of genes (specifically, DNA sequences) is to attend to 14 
their only evolutionary interest: to continue being replicated -not necessarily for the benefit of the 15 
organism they are in. This means that each organism's body just provides the survival and 16 
dissemination machinery for the genes it contains. To be sure, inspection of many DNA segments - 17 
especially those encoding mobile elements (insertion sequences, transposons, plasmids etc.) - would 18 
suggest that they have self-propagation as their only biological program [20]. Typically, IS elements 19 
encode an enzyme, the only known function of which is to make its own DNA sequence hop between 20 
different locations in the genome [21]. Examination of the environmental “mobilome” has also revealed a 21 
high incidence of plasmids consisting of a circular DNA sequence encoding only a replication protein 22 
and an origin of replication for the corresponding sequences [22,23]. Inteins are one case of extreme 23 
and sophisticated DNA selfishness: intein-mediated protein splicing occurs after the intein-encoding 24 
sequence has been transcribed into mRNA and then translated into a polypeptide, thereby avoiding 25 
counterselection due to loss of protein function [24]. Evolutionary biologists make a subtle difference 26 
between selfish genetic elements or parasitic genetic elements, depending on whether they contribute 27 
more or less to the fitness of the host organism. The ultimate role of such jumping genes is intriguing, as 28 
game theory suggest that they go beyond apparent self-interest and may become ultimately 29 
advantageous to the population [25]. But can one take for granted that all DNA is (to various degrees) 30 
selfish just because some sequences look like it? 31 
 5 
 1 
One cannot underestimate the influence that Dawkins’ metaphor has had in subsequent generations of 2 
Life Sciences researchers, as it marked the commencement of what one could call the DNA-centric or 3 
gene-centric era of Molecular Biology, not to mention an equally gene-centric view of evolution that 4 
influences us to this day. And this is not just an academic enterprise: the DNA-is-king paradigm has 5 
direct biotechnological implications: control the DNA and you dominate the biological system it encodes. 6 
The dividends of such a notion are evident. To name but a few examples, moving genes around with 7 
the tools of genetic engineering (and more recently with straight DNA synthesis) has allowed 8 
Escherichia coli to produce antimalarial drug precursors [26] and even gasoline [27], yeasts to produce 9 
insulin [28], plants to produce plastics [29] and cows to produce therapeutic agents [30]. But the DNA-10 
rules allegory implicit in the CD has spinoffs in other research endeavours that have been less rosy and 11 
which, in fact, challenge the tenet as a whole.  12 
 13 
Changing DNA is insufficient for (re)programming biological systems 14 
 15 
Let us take, for instance, metabolic engineering of environmental bacteria as agents for bioremediation 16 
of xenobiotic pollutants released by the chemical industry [31,32]. The zeitgeist of the mid-80s, at the 17 
peak of the recombinant DNA hype, was that one could gather genes from various origins (whether 18 
naturally-occurring or artificially improved e.g. in substrate specificity), assemble them in a rational way 19 
for a given biotechnological purpose, express them in a heterologous host and many (if not all) of 20 
mankind’s problems would be gone [33]! But subsequent research soon watered down this somewhat 21 
naïve perspective. Genetic engineering from the late 80s to the early 2000s did produce a number of 22 
bacterial strains with enhanced biodegradative capacities. But the recombinant strains maintained their 23 
non-natural phenotypes only under the very controlled selective conditions of the laboratory [34]. 24 
Release of such Genetically Engineered Microorganisms (GEMs) in actual environmental niches on 25 
which the user had no or little control typically resulted in loss of the knocked-in phenotypes, and 26 
takeover by resident bacteria. Very few cases are reported in the literature in which GEMs proved to be 27 
better than naturally occurring microbes as bioremediation agents. The problem was not due to a dearth 28 
of genetic tools: a large number of genome editing strategies allows insertion of heterologous genes in 29 
the chromosome of bacterial hosts with a degree of stability that is virtually identical to that of natural 30 
counterparts [35,36]. Something similar happens with recombinant strains engineered for running 31 
 6 
whole-cell catalysis in a bioreactor. Even if the recombinant strain is subject to a strong selective 1 
pressure (e.g. antibiotics added to the medium) for maintaining and expressing the genes of interest, 2 
the activity decreases over time in a sort of “catalytic fatigue” –a phenomenon well known to industrial 3 
biotechnologists [37].  4 
 5 
More recently, synthetic biologists have created a large number of genetic circuits in which transcription 6 
factors and promoters are rationally re-connected following a man-made blueprint aimed at 7 
programming new-to-nature properties e. g. oscillators, toggle switches, light-sensing and many others 8 
[38,39]. But, again, it is now common knowledge that such devices operate for a limited period of time, 9 
after which they succumb to noise and mutations. One remarkable case is that of the T7 phage genome 10 
that was entirely re-factored to make it amenable to forward engineering by decompressing regulatory 11 
regions and arraying the various functional sequences in an ordered and standardized fashion [40]. 12 
Although the resulting virus was certainly infective, its subsequent evolution in vivo whilst progressing 13 
towards recovering the fitness level of the wild-type phage erased ~ 40% of man-made modifications 14 
[41]. In contrast, naturally occurring regulatory circuits are quite robust, and maintain their performance 15 
across time and space.  16 
 17 
Taken together, all of the above suggest that changing the instructions (the DNA) is not sufficient for 18 
ensuring that the whole biological system duly obeys the orders coming from the top of the CD. Instead, 19 
it seems that the physiology of the host, of which metabolism is the key component, has a say in 20 
whether the directions from DNA are to be implemented or not. This becomes yet more manifest when 21 
the DNA-encoded instructions are aimed at changing the biochemical regime of cells: metabolism itself 22 
is most difficult to manipulate. A few examples illustrate this circumstance. Knocking-in 23 
phosphofructokinase of E. coli into Pseudomonas putida was unable to generate a glycolytic regime in 24 
this bacterium, which naturally consumes sugars through the Entner-Doudoroff pathway [42]. Attempts 25 
to alter genetically the biosynthetic flux of the pyrimidine pathway in E. coli could not defeat the 26 
homeostasis accomplished by the indigenous directed overflow metabolism [43]. Systematic study of 27 
the metabolic regimes of large collections of E. coli mutants [44,45] revealed only small variations in 28 
metabolite levels, indicating a rerouting of fluxes in the metabolic network that otherwise tolerates a 29 
large number of genetic changes. This reveals the extraordinary robustness of the cell biochemistry 30 
against perturbations coming from DNA, and somehow challenges its position at the summit of the CD 31 
 7 
hierarchy. At the very least, one should concede that the operativity of the information/command chain 1 
from DNA to the downstream actors is constrained by metabolism, to the point that physiological 2 
imbalances may ruin it altogether (Fig. 1c). But there are more grounds yet for questioning the position 3 
of DNA as the leading character of the biological play. 4 
 5 
Pathogenesis is not only about virulence determinants 6 
 7 
Bacterial pathogenicity is a complex phenomenon in which given germs endowed with a number of 8 
advantageous traits penetrate animal or plant tissues to the detriment of the whole afflicted organism. 9 
The standard view is that virtually all bacteria with ecological compatibility with the host (for instance 10 
able to grow at body temperature) have the potential to become pathogens were it not for the 11 
permanent surveillance that the immune system imposes on any microbe that the body interacts with 12 
[46]. This explains how generally innocuous microorganisms that reside in diverse body habitats (gut, 13 
skin etc.) may become pathogenic in immune-compromised individuals. The boundary between 14 
pathogenic and non-pathogenic microbes is therefore a bit fuzzy, although some examples clearly map 15 
to the extremes. For instance, Lactobacillus acidophilus or Bifidobacterium are generally considered 16 
human-friendly, whereas species such as Salmonella typhimurium, Shigella flexneri, Listeria 17 
monocytogenes -not to mention enteroinvasive, enteropathogenic or enterohemorrhagic E. coli count 18 
among the most dreaded species [46]. What, then, makes a virulent strain virulent? Under the CD 19 
paradigm, the way to go for answering this question is the identification of genes (i.e. DNA) that 20 
determine such a quality.  21 
 22 
In a series of papers from the mid-90s, J. Mekalanos [47] and D. Holden [48] proposed the first genetic 23 
tools for what would later be called in vivo expression technology (IVET [49,50]). The objective of that 24 
seminal work was to identify which genes of Salmonella were specifically turned on and off during 25 
experimental infection of laboratory mice. The procedures yielded lists of genes that were candidates for 26 
a role in pathogenesis. It is interesting that metabolic genes were largely ignored: only those that looked 27 
like accredited virulence or colonization factors were followed up. Increasingly sophisticated IVET 28 
methods have been used to search for such factors in a broad diversity of pathogens (see e.g. [51] and 29 
many others). Systematically, the resulting lists contain a large share of metabolic and transport genes 30 
and only a handful of specific-looking virulence factors (e.g. type-III / IV secretable effectors, adhesins, 31 
 8 
haemolysin etc). The same is true for other pathogenesis-related phenomena e.g. formation of biofilms. 1 
Every survey has revealed most genetic actors of biofilm development to be metabolic: only a few 2 
others encode “attention-grabbing” functions [52]. But then comes the power of the geno-centric 3 
paradigm: metabolic functions recorded in every index of virulence culprits are largely ignored and 4 
(more or less deliberately) removed from view, as if metabolism had no business in the standard CD. Is 5 
it because metabolism is seen as boring or unimportant [53]? One way or the other, virtually all IVET 6 
projects end up studying the non-metabolic genes that participate in pathogenesis, while the 7 
biochemical players are often consigned to oblivion. But is this ultimately correct? In every conflict (and 8 
virulence is a clear case) the most ostentatious actors may not be the ones that are ultimately decisive. 9 
In fact, focusing on the most eye-catching components of a virulence program could be misleading if 10 
one disregards the metabolic and physico-chemical context in which the phenomenon occurs.  11 
 12 
Virulence accompanies the conquest of new chemical landscapes 13 
 14 
Metabolism is the economy of living systems. Very few things can happen if instructions coming from 15 
one or other gene antagonize the kinetic and thermodynamic optima of the cognate biochemical 16 
network of the living carrier. Quite on the contrary, the quest for such metabolic optima is the code that 17 
is recorded in the virulence program of pathogens and not vice versa (i.e. not DNA instructing the 18 
downstream components of the CD for its own sake). This is a serious argument for up-ending the chain 19 
of command of the CD as shown in Fig. 1c (not yet the handover of information, see below). In this way 20 
metabolism becomes the chief player, on top, and DNA is the clerk that duly archives instructions, 21 
based on past experiences, keeping the master satisfied. Following on with the same analogy, one may 22 
recall that the alphabet and the first written records were invented for the sake of keeping track of 23 
economic transactions and fixing rules for sorting conflicts out. Along the same lines, one could argue 24 
that DNA was invented as a repository of information to keep a record of already existing metabolic 25 
phenomena as well as a sort of memory for re-enacting biochemical reactions when needed. This is the 26 
stance of the metabolism-first view of the Origin of Life, which rejects the idea of naked self-replicating 27 
molecules (e.g. RNA), and suggests instead a seminal metabolism centred on primitive and growingly 28 
complex metabolic reactions [54-58] and cycles [59-61]. These could result in generating amino acids 29 
and nucleotides, which ultimately led to the emergence of RNA replication. Whether this theory is 30 
entirely correct or not, it seems clear that a complex network of (bio)chemical reactions was at some 31 
 9 
point possible without genes, but genes or other replicative molecules are not possible without 1 
metabolism [62]. 2 
 3 
Considering biochemical networks (not DNA) as the master of a vast variety of biological occurrences 4 
could bring both conceptual and methodological changes in the way many phenomena observed in 5 
living systems are addressed - including pathogenesis. The selfish gene paradigm encourages us to 6 
focus on the specific DNA sequences that determine the most immediate virulence phenotypes. The 7 
alternative chemo-centric view implicates the drive of the pathogen’s metabolic network in the conquest 8 
of new plots of the chemical landscape of the host for its own sake (Fig. 2). The selfish gene metaphor 9 
can thus justifiably be replaced by the alternative analogy of selfish metabolism. In the first case, the 10 
evolutionary agenda of pathogens is the preservation and spreading of the DNA born by the bacteria in 11 
question. In the other case, the driving force of virulence is the thermodynamic pull to integrate available 12 
substrates into one’s own biochemical network. While the two agendas are perfectly compatible, there 13 
should be no doubt that chemistry and metabolism prevail over genetics.  14 
 15 
Metabolism enables virulence 16 
 17 
On the basis of the foregoing, what could, then, determine bacterial pathogenesis –if not the end-of-the-18 
pipe: those conspicuous virulence factors? In some cases, the difference can be made by the 19 
possession of biochemical pathways that exploit as nutrients some of the proprietary metabolites of the 20 
host. Various examples can be found in the literature on pathogens that do exactly that. For instance, 21 
Mycobacterium tuberculosis, the cause of two million deaths per year, is able to survive for long periods 22 
of time within the host because virulent strains can also utilize the cholesterol of the target cells as a 23 
growth substrate [63,64]. As a consequence, deletion of the genes for metabolism of this steroid 24 
BOX 1. Could metabolic networks be selfish evolutionary entities able to autonomously accept and 
reject incoming traits? A precedent of this view is the metabolon or structural-metabolic cellular complex, 
as conceived by Srere [109]. In this case, reception or dismissal of new activities by such metabolic 
systems is exerted through e.g. adoption or silencing of particular genes. This means that metabolism 
can modify the genome, shaping its blueprint and granting inheritance of particular sets of encoded 
functions -and thus reversing the conventional directionality of the CD flowchart. According to S. J. 
Gould [1] there is a set of minimal criteria for defining an evolutionary object (reproduction, inheritance, 
variation, interaction). While the selfish metabolism proposed in this article has attributes of a true 
evolutionary entity, it is intertwined with the genome as the storehouse of information.   
 
 10 
decreases M. tuberculosis virulence (it should be kept in mind for the later discussion, that Mycobacteria 1 
count among the bacterial species that more frequently develop new metabolic routes for environmental 2 
xenobiotic and recalcitrant chemicals [65]). Along the same lines, it is known that scarcity of nicotinic 3 
acid, a precursor of the central cofactor NAD+, elicits a large number of virulence traits in various 4 
pathogens. In a remarkable case, the lack of NAD in Shigella spp. due, for example, to mutation of the 5 
nadB gene (encoding L-aspartate oxidase)  - which disrupts synthesis of quinolinate - is required for 6 
virulence. It is thus the lack of a metabolic precursor that triggers the pathogenesis program in this case 7 
[66,67]. Similarly, Burkholderia strains, which are most frequent inhabitants of cystic fribrosis (CF) 8 
patients’ lungs need to catabolize phenylacetic acid as part of their virulence package [68,69]. A more 9 
sophisticated example is provided by the resident of the canine buccal cavity that causes septicaemia in 10 
humans, called Capnocytophaga canimorsus. This bacterium has the habit of feeding on mammalian 11 
cells by harvesting the glycan moiety of glycoproteins i.e. shaving the glycans away from the 12 
glycosylated proteins of the cell surface and using them as nutrients [70,71]. As a consequence, the 13 
virulence of pathogenic strains depends on the activity of feeding complexes displayed on the bacterial 14 
envelope that are reminiscent of the celullosomes of some environmental bacteria [72]. As expected, 15 
these complexes are essential for growth of the pathogen on cells, and for survival in mice.  16 
 17 
But the metabolic drive of pathogens involves not only peripheral functions for wresting nutrients from 18 
the host (cholesterol, glycans, nicotinic acid etc) but it also engages central metabolic routes. And the 19 
connection is not just for the sake of feeding, but for enduring stress as well. Alas, the link of virulence 20 
with core metabolic transactions is more difficult to detect by just looking at the genes, as the primary 21 
sequences of enzymes for most central reactions are very similar, and the genes themselves quite 22 
conserved. Some recent observations, however, shed light on how some metabolic regimes contribute 23 
to virulence in various ways. It is well known that macrophages constitute one of the first lines of 24 
defence against infections - by phagocytosis of the bacteria followed by release reactive oxygen species 25 
(ROS) to kill the invaders [73]. The ability of enduring oxidative stress is linked to production of NADPH, 26 
the decisive metabolic currency that feeds the enzymes for countering ROS exposure. Interestingly, not 27 
all metabolic regimes are equally efficient at producing NADPH, the cycle of pentoses and the Entner-28 
Doudoroff (ED) pathway for sugar consumption being better for this specific role that the standard 29 
Embden-Meyerhof-Parnas glycolysis [74]. In light of this, it cannot come as a surprise that the ED 30 
pathway has recently been shown to be essential for infection in the case of bacteria that have to cope 31 
 11 
with oxidative stress during their intracellular lifestyle [75,76]. Other pathogens display somewhat odd 1 
host adaptation strategies that are yet more alien to the selfish gene metaphor. One intriguing case is 2 
that of the establishment of chronic infections of Pseudomonas aeruginosa in CF patients. Following 3 
years of antibiotic treatment and strong selective pressure, CF strains appear to enter a dead-end route 4 
characterized by the emergence of hypermutator phenotypes and pseudogenization of a good share of 5 
the genomic complement [77,78]. This seems to silence expression of most virulence factors that are 6 
customary for these pathogens. Moreover, once engaged in a chronic infection lifestyle, CF bacteria 7 
have a very slow growth rate, but still accompanied by activity of specific portions of the basal 8 
metabolism (in particular the glyoxylate shunt, [78-80]). In this case, the outcome of the process seems 9 
to be more directed to ensuring biochemical activity of the cells for as long as possible rather than 10 
spreading of their DNA (in fact, bacterial DNA of the terminal CF patients is not replicated or transmitted 11 
at all). Similarly, endosymbionts (e.g. Buchnera) appear to run a reduced but active metabolic network 12 
(they get most metabolites from the environment [81]) while they seem to have lost the ability to fix DNA 13 
damage [82]. Could these be yet other cases in which metabolism is the master and DNA the servant? 14 
If this were so, the quest for antimicrobials against infectious agents – whether acute or chronic, could 15 
be redirected to disabling central metabolic functions e.g. generation of NADPH or the glyoxylate cyle 16 
[83] instead of the habitual targeting of functions necessary for cell growth.  17 
 18 
Virulence and biodegradation stem from the same evolutionary drive 19 
 20 
Although strategies for feeding on unusual substrates and tolerating ROS can be considered virulence 21 
factors in the context of pathogenesis, the same drive that pushes agents of disease to conquer new 22 
plots of chemical landscape of the host also empowers environmental bacteria to explore ways of 23 
degrading unusual chemical species. Researchers have not failed to notice that routes for 24 
biodegradation of xenobiotic and recalcitrant chemicals are not infrequent in bacteria generally 25 
considered pathogenic [84]. Just to name a few, a considerable number of environmental isolates 26 
selected for catabolism of chloroaromatic and nitroaromatic compounds turn out to be strains of 27 
Burkholderia sp. a genus, the pathogenic members of which cause various diseases (e.g. glanders, 28 
melioidosis) and often aggravate pulmonary infections of CF patients (see above; [85]). Mycobacteria, 29 
including strains of M. leprae, are recurrently isolated in screenings of strains able to degrade 30 
polyaromatic hydrocarbons, a side product of the oil industry [65]. Even some P. aeruginosa strains can 31 
 12 
grow on alkanes as the sole carbon source [86,87]. G. Church’s team reported a few years ago that a 1 
surprising number of soil bacteria can not only resist, but also metabolise antibiotics as growth nutrients 2 
[88]. These observations suggest once more that the divide between pathogenic and non-pathogenic 3 
bacteria is more a human construct than a description of an authentically different biological program. 4 
Virulence and the ability to deal with unusual chemicals may stem from the same central metabolic 5 
drivers. Pathogens whose metabolism has evolved to counteract oxidative stress in macrophages might 6 
subsequently become optimal vehicles for hosting the evolution of biodegradation pathways for 7 
recalcitrant compounds, a process also associated with redox stress [89-91]. By the same token, there 8 
is a continuum of growing toxicity in the chemical structures that bacteria meet during their lifetime: from 9 
bona fide nutrients, to recalcitrant compounds to xenobiotics and antibiotics. The indigenous metabolic 10 
network of bacteria, whether virulent or not, tends to expand its reach towards the chemical landscapes 11 
of the surrounding environment. As sketched in Fig. 2, the evolutionary process involves the 12 
progressive incorporation of abiotic and xenobiotic compounds to the pool of molecules that are 13 
recognized as actual or potential nutrients. The endogenous and exogenous stress that is inherent to 14 
the intermediate stages can be mitigated –both during virulence and biodegradation - by the redox 15 
metabolic currency (e.g. NADPH) produced by core metabolic pathways. This takes us to the last point 16 
of this article: how do existing biochemical networks explore the solution space for metabolizing a 17 
compound that they may never have seen before, and how is such a solution ultimately recorded in 18 
DNA? 19 
 20 
ROS enables a feedback loop to the CD 21 
 22 
The process by which given bacteria evolve to degrade a new xenobiotic chemical is not trivial. While 23 
resistance to antibiotics can be endowed by either simple mutations in the target or horizontal genetic 24 
transfer of enzymes that inactivate the antimicrobial, the emergence of a new metabolic pathway is a 25 
different, stepwise, and more complicated matter. Pre-existing enzymes have to acquire new substrate 26 
specificities, and the shape and kinetics of the enzymes involved fit to each other to avoid the escape of 27 
intermediates [84,92]. In addition, the flow of the resulting products has to be wired to the extant 28 
biochemical network in order to generate a growth advantage that allows its selection. This typically 29 
requires multiple changes in both the catabolic genes at stake and in the rest of the cell physiology. 30 
Finally, such evolution happens in extremely competitive environmental niches inhabited by many other 31 
 13 
microorganisms, meaning that the process cannot afford much loss of fitness during the intermediate 1 
steps. Environmental bacteria that partially degrade 2,4-dinitrotoluene (DNT) have been isolated which 2 
provide an exceptional experimental system to examine the transition between a precursor pathway for 3 
catabolism of the naturally-occurring hydrocarbon naphthalene and the new xenobiotic substrate DNT 4 
[93,94]. Recent data on this system [89] have revealed an intriguing mechanism by which the first 5 
enzyme of the biodegradation pathway (a Rieske-type dioxygenase) that acts on the substrate-to-be 6 
(DNT) may uncouple the reaction because of poor specificity, and generate a high level of endogenous 7 
reactive oxygen species (ROS). This, in turn, damages DNA (and possibly DNA repair proteins as well 8 
[95]) and increases mutagenesis, ultimately resulting in the creation of novelty that fosters evolution of 9 
xenobiotic-degrading variants of the strain hosting the pathway (Fig. 3). The metabolic problem thus 10 
stimulates the exploration of the solution space, as the stress caused by faulty dioxygenation of DNT 11 
accelerates the rate of bacterial change. It is plausible that such an evolutionary scenario is widespread, 12 
because many other oxygenation reactions are known to withstand a degree of ROS production that 13 
depends on the more or less obligate coupling of the substrate to the redox enzyme [96-99]. 14 
 15 
The picture of metabolically-fostered ROS-driven hypermutation and ensuing genetic variation is 16 
reminiscent -but different - to that proposed for the evolution of antibiotic resistance. At least in E. coli, 17 
this has been suggested also to be stimulated by mutagenic stress in cells treated with antimicrobials 18 
[100,101]. In contrast, in the DNT biodegradation case (and plausibly in other metabolic reactions of that 19 
sort) the trigger of the adaptive process can be traced to the master oxygenation that initiates the 20 
pathway. The gain of a new metabolic ability is essentially different from resisting an antibiotic: in the 21 
selfish metabolism paradigm the biological system does not merely escape a lethal pressure: it 22 
conquers another portion of the chemical landscape i.e. it pushes further into the thermodynamic 23 
BOX2. Oxidative stress and emergence of antibiotic resistance. It has been proposed that, following 
disruption of basic cellular functions, virtually all antibiotics kill bacteria by triggering intracellular 
production of ROS [110,111]. Similarly to the scenarios entertained in this article, such ROS could in 
turn mutate DNA and generate genetic and phenotypic novelty leading to the rise of resistance towards 
the same antibiotic that causes the problem –or other antimicrobials [100,101]. In this context, 
counteracting oxidative stress by stimulating NADPH-producing metabolic pathways could be a clear 
fitness trait of pathogens during infection regardless of the origin of ROS: externally in the case of 
phagocytosis by macrophages or internally upon antibiotic treatment. However, whether this is a general 
principle, and whether all antibiotic stresses are ultimately converted into lethal ROS levels, are 
questions still debated at the time of writing this review [103,112-115]. 
 
 14 
interface between chemistry and biology –and for its own sake (Fig. 2).  1 
 2 
The transient regime experienced by bacteria under ROS-producing metabolic stress is in fact worth 3 
examining in detail. On the one hand, it is possible that while cells accumulate both adverse changes 4 
(surely most of them) and beneficial (few) modifications, the fitness of the lineages is buffered by 5 
overproduction of chaperones. This circumstance that has been observed in E. coli when artificially 6 
subject to a high-mutation rate [102] may well happen in natural settings. On the other hand, ROS alters 7 
protein structure (thereby changing enzymatic activities as well [95]) and may also cause mistranslation 8 
due (among other things) to the incorporation of 8-oxo-guanine into newly synthesized RNAs [103]. This 9 
means that the biochemical diversity of cells exposed to ROS might, in reality, be broader than the 10 
inherited genetic diversity of the progeny. This opens intriguing evolutionary scenarios that are beyond 11 
the scope of this article. Since oxygen appeared on the Biosphere > 1 billion years after the emergence 12 
of the first bacteria [104] it is evident that evolution does occur also in its absence (e.g. some archetypal 13 
pathogens are strict anaerobes). Still, it seems clear that a suite of metabolic reactions, specially those 14 
producing ROS can accelerate the process directly or indirectly.  15 
 16 
Conclusion -outlook 17 
 18 
The gene-centric view of evolution that has dominated biological thought for a number of decades has 19 
its more radical expression in the selfish gene concept, which is itself an extreme spinoff of the CD. But 20 
new data stemming from fields as remote as bacterial pathogenesis, biodegradation and Origin of Life, 21 
as well as new methods for studying the metabolome and the fluxome force us to qualify some of the 22 
implicit claims of this most influential of biological metaphors. First, metabolism must be included in the 23 
information flow. Information travelling between RNA, DNA and protein is easy to visualize. In contrast, 24 
deconvoluting protein sequences into production of chemicals and fluxes is more difficult –but the 25 
information is indeed there. Second, the biochemical network has its own autonomous drive, which 26 
constraints the execution of instructions from DNA more than vice versa. This calls for a conceptual 27 
change in which metabolism has the leading position in the chain of command [105] -which is different 28 
from the customary direction of the information flow (e.g. Fig. 1a). And, third, the CD is not exclusively a 29 
one-way stream of instructions. Faulty enzymatic steps on suboptimal substrates (in particular 30 
oxygenations and other redox reactions) can produce ROS, which feed back on DNA and thereby 31 
 15 
create biological novelty. While the informational relationships DNA à metabolism are fairly strict 1 
(though not exclusively codified), the feedback metabolism à DNA has a different quality i.e. a sort of 2 
mandate for exploring the solution space but without specifying any outcome (Fig. 4). In reality, all DNA 3 
sequences are subject to spontaneous changes which, given enough time, can make the coding 4 
sequence of existing enzymes to change substrate specificity and contribute to what has been called 5 
paralogous metabolism [106]. Metabolic stress in general and ROS-mediated mutagenesis originated in 6 
defective biochemical reactions in particular seems thus to enable a wider creation of novelty in a much 7 
faster fashion. This surely gives an advantage to the bacterial carrier in the very competitive 8 
environmental scenarios were microorganisms live. It is plausible that such metabolic stress-driven 9 
evolution of new traits accounts for a plethora of rapid adaptation phenomena that cannot be explained 10 
by the mere genetic drift of the DNA sequences at stake [107,108]. 11 
 12 
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FIGURES 1 
 2 
Figure 1. The growing expansion of the Central Dogma (CD).  3 
 4 
 5 
 6 
A: Canonical CD. The flux of information goes uni-directionally from DNA to proteins (general flow), 7 
though exceptionally RNA can also replicate by itself and be copied into DNA (special CD). B: Extended 8 
CD. The connection of proteins to metabolism is made explicit. Note that the information handover DNA 9 
à RNA à proteins involves a direct code, whilst that of proteins à metabolism has various layers of 10 
convolution. C: Metabolism constrains the information flow. This upside-down sketch emphasizes the 11 
dominant role of metabolism in enabling the enactment of the CD flow. Whilst the effect of metabolism 12 
on biosynthesis of information-bearing macromolecules is indirect, it does ensure that the instructions 13 
emanating from DNA do not conflict with the existing biochemical network. This can be interpreted as a 14 
feedback loop whereby metabolism informs the CD actors to proceed or not with the information flow 15 
according to physiological conditions.  16 
 17 
18 
 25 
Figure 2. The conquest of new plots of the chemical landscape.  1 
 2 
3 
The graph sketches the evolutionary push of pathogens and biodegradative environmental bacteria as 4 
the growing occupation (biologization) of the chemical landscape of the target niche. Every chemical 5 
available maps somewhere in a space defined by 3 parameters: available concentration, toxicity and 6 
biodegradability. The last is a parameter that can be scored based on the distribution of atomic triplets 7 
in the chemical structure and the familiarity of such structure with core biomolecules [116]. The process 8 
of niche colonization can be seen as the progressive exploration of the existing chemical scenery in 9 
order to integrate it into one’s metabolic network (i.e. transformation of xenobiotics and unfamiliar 10 
chemicals into endo- and exo-metabolites).  11 
 12 
13 
 26 
Figure 3. The metabolic stress-novelty cycle.  1 
2 
A: Reaction catalyzed by the 2,4-dinitrotoluene dioxigenase (DntA) of Burkholderia sp DNT. This 3 
enzyme seems to have originated in a precursor naphthalene dioxigenase that has acquired the (partial) 4 
ability to use DNT as a substrate. B: Production of reactive oxygen species upon faulty oxidation of DNT 5 
at the non-heme Rieske active center of DntA. C: The novelty creation cycle. The figure represents the 6 
process through which a strain able to degrade compound A ends up degrading compound B. The ROS 7 
produced by faulty dioxygenation both places the population at the verge of collapse but simultaneously 8 
diversifies genetically the same population and thus fosters the exploration of the solution space. Those 9 
individuals that survive the process (if any) have thus gained a new fitness peak. [89] has previously 10 
argued that this is an anti-fragile cycle, as long as the system ultimately benefits from shocks.    11 
 12 
13 
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Figure 4. A feedback loop metabolism à DNA in the CD.  1 
 2 
 3 
 4 
The figure sketches the main claims of this article. Metabolic troubles (e.g. faulty oxidation of no-5 
substrates or poor substrates of oxygenases) cause ROS, which mutates DNA (as well as damaging 6 
RNA), triggers the SOS response and brings about genetic diversification, which might find a solution to 7 
the metabolic problem that originates the release of the mutagenic agent. While the ROS à DNA loop 8 
does not involve transfer of coded information it does deliver an input that accelerates the rate of 9 
novelty production.  10 
 11 
 12 
